Amid a shakeup in U.S. science, researchers are expressing alarm over the integrity of key genetic databases overseen by the ...

GeneDx CEO Katherine Stueland likes the potential of newborn testing, but she says her Stamford, Connecticut, company is ...

A stand-alone sequencing approach was accurate, cost effective and efficient for analyzing resistant pathogens and determining their health care-associated transmission, researchers found.

A research team has achieved a gapless assembly of Syntrichia caninervis's genome, totaling 323.44 Mbp with an N50 value of ...

A groundbreaking study reveals how a rare combination of genetics, proteomics, and environmental factors may hold the key to delaying or preventing Alzheimer's, challenging long-held assumptions about ...

The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more ...

Every cell in your body contains the same genetic sequence, yet each cell expresses only a subset of those genes. These ...

While wastewater already is being tested for the presence of bird flu, the genetic sequence of the virus isn’t being studied ...

GAITHERSBURG, Md. - GeneDx (NASDAQ: WGS), a genomic insights company valued at $1.64 billion, has launched its services on Aura, Epic's specialty diagnostics suite, to facilitate advanced genetic ...

Dr. Suneel Kamath discusses the ALASCCA study in colorectal cancer and highlighted the importance of next-generation sequencing and testing.

Technological advances have reduced genome sequencing costs to $600, boosting growth in the genomics sector. The genetic testing market is forecast to hit $91.3 billion by 2034, enhancing disease ...